ResMed Inc (RMD) - Financial and Strategic SWOT Analysis Review
Description
ResMed Inc (RMD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
ResMed Inc (ResMed) is a medical device company. It develops, manufactures, and distributes medical equipment for the diagnosis, treatment, and management of respiratory disorders such as sleep-disordered breathing (SDB), sleep apnea and chronic obstructive pulmonary disease (COPD). Its major products include airflow generators such as continuous positive airway pressure (CPAP) devices, auto-bilevel devices, variable positive airway pressure (VPAP) devices, and automatic positive airway pressure (APAP) devices. The company distributes its products in various countries through a combination of distributors and direct sales teams. ResMed also offers software as a service (SaaS) to out-of-hospital health providers. The company sells its products to sleep clinics, home healthcare dealers, and third-party payers. ResMed is headquartered in San Diego, California, the US.
ResMed Inc Key Recent Developments
Oct 30,2025: Resmed Inc. Reports First Quarter Fiscal Year 2026 Results
Oct 13,2025: Fractus Files Patent Infringement Complaint Against ResMed in Southern District of California
Sep 03,2025: Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
Aug 27,2025: Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
The profile contains critical company information including:
- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
ResMed Inc (ResMed) is a medical device company. It develops, manufactures, and distributes medical equipment for the diagnosis, treatment, and management of respiratory disorders such as sleep-disordered breathing (SDB), sleep apnea and chronic obstructive pulmonary disease (COPD). Its major products include airflow generators such as continuous positive airway pressure (CPAP) devices, auto-bilevel devices, variable positive airway pressure (VPAP) devices, and automatic positive airway pressure (APAP) devices. The company distributes its products in various countries through a combination of distributors and direct sales teams. ResMed also offers software as a service (SaaS) to out-of-hospital health providers. The company sells its products to sleep clinics, home healthcare dealers, and third-party payers. ResMed is headquartered in San Diego, California, the US.
ResMed Inc Key Recent Developments
Oct 30,2025: Resmed Inc. Reports First Quarter Fiscal Year 2026 Results
Oct 13,2025: Fractus Files Patent Infringement Complaint Against ResMed in Southern District of California
Sep 03,2025: Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
Aug 27,2025: Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Table of Contents
66 Pages
- Section 1 - About the Company
- ResMed Inc - Key Facts
- ResMed Inc - Key Employees
- ResMed Inc - Key Employee Biographies
- ResMed Inc - Major Products and Services
- ResMed Inc - History
- ResMed Inc - Company Statement
- ResMed Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Section 2 – Company Analysis
- Company Overview
- ResMed Inc - Business Description
- Business Segment: Residential Care Software
- Overview
- Performance
- Business Segment: Sleep and Breathing Health
- Overview
- Performance
- Geographical Segment: Rest of the World
- Performance
- Geographical Segment: United States
- Performance
- R&D Overview
- ResMed Inc - Corporate Strategy
- ResMed Inc - SWOT Analysis
- SWOT Analysis - Overview
- ResMed Inc - Strengths
- ResMed Inc - Weaknesses
- ResMed Inc - Opportunities
- ResMed Inc - Threats
- ResMed Inc - Key Competitors
- Section 3 – Company Financial Ratios
- Financial Ratios - Capital Market Ratios
- Financial Ratios - Annual Ratios
- Performance Chart
- Financial Performance
- Financial Ratios - Interim Ratios
- Financial Ratios - Ratio Charts
- Section 4 – Company’s Lifesciences Financial Deals and Alliances
- ResMed Inc, Medical Equipment, Deals By Year, 2019 to YTD 2025
- ResMed Inc, Medical Equipment, Deals By Type, 2019 to YTD 2025
- ResMed Inc, Recent Deals Summary
- Section 5 – Company’s Recent Developments
- Oct 30, 2025: Resmed Inc. Reports First Quarter Fiscal Year 2026 Results
- Oct 13, 2025: Fractus Files Patent Infringement Complaint Against ResMed in Southern District of California
- Sep 03, 2025: Resmed Launches Sleep Institute to Elevate Sleep Health as a Global Priority
- Aug 27, 2025: Obstructive Sleep Apnea Expected to Affect Nearly 77 million U.S. Adults by 2050, New Resmed Study Finds
- Aug 18, 2025: Resmed Appoints Nicole Mowad-Nassar to Board of Directors
- Jul 31, 2025: Resmed Announces Results for the Fourth Quarter of Fiscal Year 2025
- Jul 31, 2025: ResMed : Resignation
- Jul 21, 2025: Oxygen Therapy Devices Market Set for Steady Expansion by 2032, Driven by Fisher & Paykel Healthcare, Masimo, Vapotherm, BMC Medical, ResMed, Allied Medical , Hamilton Medical, Neote
- Apr 23, 2025: Resmed Posts Results for Q3 of Fiscal Year 2025
- Apr 23, 2025: Resmed Announces Results for the Third Quarter of Fiscal Year 2025
- Section 6 – Appendix
- Methodology
- Ratio Definitions
- About GlobalData
- Contact Us
- Disclaimer
- List of Tables
- ResMed Inc, Key Facts
- ResMed Inc, Key Employees
- ResMed Inc, Key Employee Biographies
- ResMed Inc, Major Products and Services
- ResMed Inc, History
- ResMed Inc, Other Locations
- ResMed Inc, Subsidiaries
- ResMed Inc, Key Competitors
- ResMed Inc, Ratios based on current share price
- ResMed Inc, Annual Ratios
- ResMed Inc, Annual Ratios (Cont...1)
- ResMed Inc, Annual Ratios (Cont...2)
- ResMed Inc, Interim Ratios
- ResMed Inc, Medical Equipment, Deals By Year, 2019 to YTD 2025
- ResMed Inc, Medical Equipment, Deals By Type, 2019 to YTD 2025
- ResMed Inc, Recent Deals Summary
- Currency Codes
- Capital Market Ratios
- Equity Ratios
- Profitability Ratios
- Cost Ratios
- Liquidity Ratios
- Leverage Ratios
- Efficiency Ratios
- List of Figures
- ResMed Inc, Performance Chart (2021 - 2025)
- ResMed Inc, Ratio Charts
- ResMed Inc, Medical Equipment, Deals By Year, 2019 to YTD 2025
- ResMed Inc, Medical Equipment, Deals by Type, 2019 to YTD 2025
Search Inside Report
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.

